Authors: LITTRELL RA SCHNEIDERHAN M

Citation: Ra. Littrell et M. Schneiderhan, THE NEUROBIOLOGY OF SCHIZOPHRENIA, Pharmacotherapy, 16(6), 1996, pp. 143-147

Authors: MILLER DD LEVY RH RALEIGH F LITTRELL RA STIMMEL GL

Citation: Dd. Miller et al., PANEL DISCUSSION, Pharmacotherapy, 16(6), 1996, pp. 166-168

Authors: LITTRELL RA MAINOUS AG KAREM F COYLE WR REYNOLDS CM

Citation: Ra. Littrell et al., CLINICAL SEQUELAE OF OVERT NONCOMPLIANCE WITH PSYCHOTROPIC AGENTS, Psychopharmacology bulletin, 30(2), 1994, pp. 239-244

Authors: LITTRELL RA MAINOUS AG KAREM F COYLE WR REYNOLDS CM

Citation: Ra. Littrell et al., CLINICAL SEQUELAE OF OVERT NONCOMPLIANCE WITH PSYCHOTROPIC AGENTS, Psychopharmacology bulletin, 30(2), 1994, pp. 239-244

Authors: LITTRELL RA POWELL J REYNOLDS C HEINE R COYLE WR STILLNER V

Citation: Ra. Littrell et al., CLOZAPINE THERAPY AND CLINICAL OUTCOMES IN KENTUCKY PSYCHIATRIC-HOSPITALS, Southern medical journal, 87(11), 1994, pp. 1092-1096

Authors: LITTRELL RA HAYES LR STILLNER V

Citation: Ra. Littrell et al., CARISOPRODOL (SOMA) - A NEW AND CAUTIOUS PERSPECTIVE ON AN OLD AGENT, Southern medical journal, 86(7), 1993, pp. 753-756